24 records matched your query
04132nam a2200373 a 4500 001 CC0E53B22AF611DEB0402C07A8D7520A 005 200904162123.0 008 960213s1996 nyua b 001 0 eng 010 $a 96004736 020 $a 9780789000620 (alk. paper) 020 $a 0789000628 (alk. paper) 035 $a (OCoLC)34245973 040 $a DLC $c DLC $d SILO $d IOD $d SILO 050 00 $a HD9665.5 $b .S776 1996 088 $a kjl 9/12/97 245 0 $a Studies in pharmaceutical economics / $c Mickey C. Smith, editor. 260 $a New York : $b Haworth Press, $c c1996. 300 $a xxii, 586 p. : $b ill. ; $c 23 cm. 504 $a Includes bibliographical references and index. 505 0 $a Pt.1. Public policy issues -- The HEW task force on prescription drugs: an insider's perspective -- Health policy initiatives and the utility of economic research -- The technology trust fund: paying for medical technology -- Medicaid drug cost containment: an economic perspective -- Public policy and drug costs: legitimate and bastard options -- Pt.2. Interventions and controls -- The Iowa Pharmacy Capitation Experiment: economic incentives and provider performance -- Incorporating severity-of-illness measures into retrospective claims-based cost-effective analyses. 505 0 $a Initial impact of a Medicaid prior authorization program for NSAID prescriptions -- Effect of a medication utilization review on Medicaid health care expenditures: a case study of patients with noninsulin-dependent diabetes mellitus -- Impact of an open formulary system on the utilization of medical services -- Pt.3. Analytical approaches -- A research framework for economic epidemiology -- Socioeconomic evaluation and the health care industry -- Assessment of a contingent valuation technique with utility estimation models. 505 0 $a Using repeated measures designs to evaluate interventions: a multivariate approach -- Pharmacoeconomic analysis of oral treatments for onychomycosis: a Canadian study -- QALYs in health outcomes research: representation of real preferences or another numerical abstraction? -- Pt.4. Prices and pricing -- Price control policies in the pharmaceutical industry: a selection of case studies -- Why Medicaid pays more: a comparison of private payment and Medicaid prescription prices, quantities, product mix, and dosage forms. 505 0 $a Physicians' perceptions of prescription drug prices: their accuracy and effect on the prescribing decision -- Does drug insurance influence physician prescribing? -- An exploratory study of physician perceptions of drug price information and a prescription price newsletter -- Toward an understanding of pharmaceutical pricing strategies through the use of single game theoretic models -- Pricing and perspectives -- Pt.5. Economics and marketing -- Content analysis of pharmacoeconomic appeals in pharmaceutical drug product advertisement -- Economics of prescription drug advertising. 505 0 $a The role of health economics in marketing new pharmaceuticals worldwide -- The benefits of pharmaceutical promotion: an economic and health perspective -- Pt.6. Economics of noncompliance -- The financial implications of initial noncompliance: an investigation of unclaimed prescriptions in community pharmacies -- Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate -- Pt.7. Effects on pharmacy -- Managed care and its effects on pharmacy services. 505 0 $a Analysis of the impact of third-party prescription programs on community pharmacy -- Third-party associated cost-shift pricing in Georgia pharmacies -- Pharmacy participation in third-party contracts: decision making through economic and financial analysis. 650 0 $a Pharmaceutical industry. 650 0 $a Pharmaceutical industry $z United States. 650 0 $a Drugs $x Prices. 700 1 $a Smith, Mickey C. 939 $a 3729922 941 $a 2 952 $l OVUX522 $d 20231017025943.0 952 $l PRAX771 $d 20090701080000.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=CC0E53B22AF611DEB0402C07A8D7520AInitiate Another SILO Locator Search